一项评估新型MDM2抑制剂APG-115（Alrizomadlin）单药或联合特瑞普利单抗治疗晚期腺样囊性癌（ACC）或其它实体瘤患者（Pts）的II期临床研究
讲者：郭晔
单位：同济大学附属东方医院
Reasons for Optimism in Treating the T-Cell Malignancies: A Biological Basis Comes into Focus
讲者：Owen O'Connor
单位：University of Virginia Comprehensive Cancer Center, USA
